Which medication class is primarily used to reduce triglyceride levels?

The medication class known for its effectiveness in reducing triglyceride levels is primarily fibric acid derivatives. These medications work by enhancing the breakdown of lipoproteins that contain triglycerides, thereby lowering their levels in the bloodstream. Fibric acid derivatives, such as fenofibrate and gemfibrozil, specifically target triglyceride metabolism and are often prescribed in cases where triglyceride levels are notably elevated, especially in patients with conditions such as hypertriglyceridemia.

Statins are mainly focused on lowering low-density lipoprotein (LDL) cholesterol and, to a lesser extent, can have some effect on triglyceride levels, but they are not the first-line treatment specifically for triglycerides. Cholesterol absorption inhibitors primarily work by preventing the absorption of cholesterol from the diet but do not significantly affect triglyceride levels. Beta blockers, while important for cardiovascular health, do not play a direct role in lowering triglycerides and are not typically used for managing lipid levels.

Thus, fibric acid derivatives are specifically designed for addressing elevated triglyceride levels, making them the appropriate choice for this question.